home / stock / tlsa / tlsa articles

TLSA Articles, Tiziana Life Sciences plc - From 11/01/23

Stock Information
Company Name: Tiziana Life Sciences plc
Stock Symbol: TLSA
Market: NASDAQ
Website: tizianalifesciences.com
Menu
TLSA TLSA Quote TLSA Short TLSA News TLSA Articles TLSA Message Board
Get TLSA Alerts

News, Short Squeeze, Breakout and More Instantly...
Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023 | Benzinga

NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company deve...
Tiziana Life Sciences plc (NASDAQ:TLSA) Short Squeeze 2023-10-16 | Squeeze Report News

Over the past twenty days of trading, Tiziana Life Sciences plc (NASDAQ: TLSA), from September 18, 2023 to October 13, 2023 there is a potential S...

Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June | Benzinga

Tiziana (NASDAQ: TLSA) is following up with anticipated human data and announced the acceptance of a late-breaking poster at the 39th Congress of t...

Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress | Benzinga

Late-breaking poster to be presented titled: "Treatment Of Six Non-Active Secondary Progressive MS With Nasal Anti-CD3 Monoclonal Antibody (Foral...
Tiziana Life Sciences Prepares To Advance Lead Intranasal Foralumab Program In First-Of-Its-Kind Phase 2a Clinical Trial for Non-Active SPMS Patients | Benzinga

Tiziana Life Sciences Ltd. (NASDAQ: TLSA) has taken a major step towards addressing Secondary Progressive Multiple Sclerosis (SPMS) by initiating P...

Poised For Growth? This Biotech Is Close To Beginning Key Phase 2a Study With Its Lead Candidate | Benzinga

Tiziana Life Sciences (NASDAQ: TLSA) is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodeg...

Tesla Cybertruck To Be Used For Oracle's Next-Gen Police Car | Benzinga

Oracle Corp (NYSE: ORCL) co-founder and Executive Chairman Larry Ellison recently made a surprising reveal during his CloudWorld talk. What Happene...
Tiziana Life Sciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference | Benzinga

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company dev...

Previous 10 Next 10